Related Experiment Video
Updated: Feb 2, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Sudden Death Risk-Stratification in 2018-2019: The Old and the New
Sarah Zaman1, Jeffrey J Goldberger2, Pramesh Kovoor3
1Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia; MonashHEART, Monash Medical Centre, Melbourne, Vic, Australia.
Insights
Sudden Cardiac Death (SCD) is a major concern. Current methods using left ventricular ejection fraction (LVEF) to guide implantable cardioverter-defibrillator (ICD) therapy are inadequate for preventing SCD.
Area of Science:
- Cardiology
- Electrophysiology
- Public Health
Background:
- Sudden Cardiac Death (SCD) accounts for half of all cardiovascular deaths globally.
- Implantable cardioverter-defibrillators (ICDs) are standard for SCD primary prevention in cardiomyopathy.
- Left ventricular ejection fraction (LVEF) is widely used but inadequate for patient selection.
Purpose of the Study:
- To evaluate the limitations of LVEF in predicting SCD risk.
- To explore alternative predictors for identifying patients who would benefit from ICDs.
- To address the challenge of accurate risk stratification for SCD prevention.
Main Methods:
- Review of current literature on SCD predictors.
- Analysis of the specificity and limitations of LVEF in patient selection for ICDs.
- Identification of emerging biomarkers and diagnostic tools for arrhythmic risk assessment.
Main Results:
- LVEF demonstrates poor specificity in distinguishing arrhythmic from non-arrhythmic death.
- A significant proportion of sudden deaths occur in patients with preserved cardiac function (higher LVEF).
- Electrophysiology studies, non-invasive electrical instability markers, myocardial fibrosis, and genetic/biomarkers show promise as alternate predictors.
Conclusions:
- LVEF alone is insufficient for selecting patients for prophylactic ICD implantation.
- New risk stratification strategies incorporating advanced markers are needed.
- Accurate identification of high-SCD-risk patients with low competing non-sudden death risk is crucial for effective prevention.
Abstract:
Sudden Cardiac Death (SCD) is a major public health issue, accounting for half of all cardiovascular deaths world-wide. The implantable cardioverter-defibrillator (ICD) has been solidified as the cornerstone therapy in primary prevention of SCD in ischaemic and non-ischaemic cardiomyopathy. However, what has become increasingly clear is that the left ventricular ejection fraction (LVEF) is an inadequate tool to select patients for a prophylactic ICD, despite its widespread use for this purpose. Use of LVEF alone has poor specificity for arrhythmic versus non-arrhythmic death. In addition, the vast majority of sudden deaths occur in patients with more preserved cardiac function. Alternate predictors of sudden death include electrophysiology study, non-invasive markers of electrical instability, myocardial fibrosis, genetic and bio-markers. The challenge for the future is finding a risk stratification test, or combination of tests, that adequately select patients at high risk of SCD with low competing risk of non-sudden death.
More Related Videos
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Related Concept Videos
SI Units: 2019 Redefinition
A standard set of units has been defined...
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment